enGene Holdings

ENGNNASDAQ
$9.20
0.22.22%
Pre-Market: 9:13 AM EDT
15 minutes delayed

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Feb
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies t...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ENGN

FAQ

Q

How do I buy enGene Holdings (ENGN) stock?

A

You can purchase shares of enGene Holdings (NASDAQ:ENGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are enGene Holdings (ENGN) competitors?

A

There are no as such competitors for enGene Holdings.

Q

What is the target price for enGene Holdings (ENGN) stock?

A

There is no analysis for enGene Holdings.

Q

What is the forecast for enGene Holdings (ENGN) stock?

A

enGene Holdings has a consensus price target of $34.40.

Q

Current stock price for enGene Holdings (ENGN)?

A

The stock price for enGene Holdings (NASDAQ: ENGN) is $9.2 last updated July 15, 2024 at 9:13 AM EDT.

Q

Does enGene Holdings (ENGN) pay a dividend?

A

A quarterly cash dividend of 0.13 per share of Class A Common Stock. The quarterly cash dividend was payable on July 8, 2015 to stockholders of record on July 1, 2015.

Q

When is enGene Holdings (NASDAQ:ENGN) reporting earnings?

A

enGene Holdings’s Q2 earnings are confirmed for Friday, June 14, 2024.

Q

Is enGene Holdings (ENGN) going to split?

A

There is no upcoming split for enGene Holdings.

Q

What sector and industry does enGene Holdings (ENGN) operate in?

A

enGene Holdings is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.